Stocktoria
CABOT CORP CBT
NYSE · XNYS · stock · Miscellaneous Chemical Products · website · IPO 1980-03-17
CABOT CORP financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $3.7B | $4.0B | $3.9B | $4.3B | $3.4B |
| Gross profit | $940.0M | $960.0M | $839.0M | $885.0M | $799.0M |
| R&D expense | $59.0M | $63.0M | $57.0M | $55.0M | $56.0M |
| SG&A expense | $260.0M | $283.0M | $253.0M | $258.0M | $289.0M |
| Operating income | $621.0M | $614.0M | $526.0M | $389.0M | $454.0M |
| Interest expense | $76.0M | $81.0M | $90.0M | $56.0M | $49.0M |
| Income tax | $196.0M | $111.0M | -$28.0M | $102.0M | $123.0M |
| Net income | $331.0M | $380.0M | $445.0M | $209.0M | $250.0M |
| EPS (diluted) | $6.02 | $6.72 | $7.73 | $3.62 | $4.34 |
| Operating cash flow | $665.0M | $692.0M | $595.0M | $100.0M | $257.0M |
| Free cash flow | $391.0M | $451.0M | $351.0M | -$111.0M | $62.0M |
| Cash & equivalents | $258.0M | $223.0M | $238.0M | $206.0M | $168.0M |
| Inventory | $504.0M | $552.0M | $585.0M | $664.0M | $523.0M |
| Total assets | $3.8B | $3.7B | $3.6B | $3.5B | $3.3B |
| Shareholders' equity | $1.7B | $1.6B | $1.4B | $1.0B | $1.1B |
Source: SEC EDGAR filings · CIK 0000016040 · as of 2025-09-30. Facts from filings plus Stocktoria's own computed scores — not investment advice.